Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088331243> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W3088331243 endingPage "S523" @default.
- W3088331243 startingPage "S522" @default.
- W3088331243 abstract "Increasing metastatic burden is associated with worsening prognosis. However, none of the current burden definitions consider metastatic lymph node volume, number and distribution. In this exploratory analysis of cross-sectional baseline staging scans from the STAMPEDE docetaxel comparison” we evaluate metastatic lymph node burden as a prognostic factor. 629 patients with metastatic disease randomised between 2005 and 2013 to Arm A (androgen deprivation therapy (ADT)) or Arm C (ADT + docetaxel) with available baseline scans were analysed. Lymph node analysis was done using the UK Royal College of Radiologists diagnostic criteria with central review of CT/MRI scans performed jointly by a radiologist and urologist. Annotation of lymph node number and size was completed for both regional and non-regional sites. Overall survival (OS) and failure-free survival (FFS) were used as endpoints. Hazard ratios were obtained separately for each treatment group using multivariable Cox regression analysis adjusted for age (<70 or ≥70), WHO PS (0 or 1-2), nodal status (N0, N1 or NX), NSAID or aspirin use (uses either or no), Gleason score (≤7, 8-10 or unknown), bone metastases counts (<5 or ≥5) and concomitant metastatic site (only metastatic lymph nodes, bone (+/-NRLN) or any visceral (+/-bone)). 178/629 (29%) patients had nodal metastases with a median maximum diameter of 2.1 (range 1.0 to 8.1) cm and median minimum diameter of 1.2 (range 0.9 to 3.9) cm. 87/629 (14%) patients had 5 or more nodes. Patients with ≥5 metastatic nodes had worse OS compared to patients with <5 nodes in both the ADT group (HR=1.61, 95%CI 1.12–2.31, p=0.013; 5yr KM estimated OS 27% for ≥5 NRLN vs 40% for <5NRLN) and ADT + docetaxel group (HR=1.79, 95%CI 1.10–2.92, p=0.024; 5yr OS 35% vs 53%). FFS was also worse for patients with ≥5 nodes in the ADT group (HR=1.51, 95%CI 1.07–2.14, p=0.024) and the ADT + docetaxel group (HR=1.78, 95%CI 1.12–2.81, p=0.018). Increased metastatic burden of 5 or more nodal metastases is an independent prognostic factor for poorer outcomes in patients with mHSPC treated with ADT or ADT + docetaxel and should be considered for inclusion along with bone metastases counts in future metastatic burden definitions." @default.
- W3088331243 created "2020-10-01" @default.
- W3088331243 creator A5000156180 @default.
- W3088331243 creator A5014097745 @default.
- W3088331243 creator A5029985009 @default.
- W3088331243 creator A5033241956 @default.
- W3088331243 creator A5033521569 @default.
- W3088331243 creator A5049145688 @default.
- W3088331243 creator A5059261043 @default.
- W3088331243 creator A5061256858 @default.
- W3088331243 creator A5064901843 @default.
- W3088331243 creator A5065195021 @default.
- W3088331243 creator A5083098699 @default.
- W3088331243 creator A5085561716 @default.
- W3088331243 creator A5088338989 @default.
- W3088331243 creator A5091666679 @default.
- W3088331243 date "2020-09-01" @default.
- W3088331243 modified "2023-10-01" @default.
- W3088331243 title "634P Impact of metastatic lymph node burden on survival in patients with mHSPC from the docetaxel comparison” of the STAMPEDE trial" @default.
- W3088331243 doi "https://doi.org/10.1016/j.annonc.2020.08.893" @default.
- W3088331243 hasPublicationYear "2020" @default.
- W3088331243 type Work @default.
- W3088331243 sameAs 3088331243 @default.
- W3088331243 citedByCount "1" @default.
- W3088331243 countsByYear W30883312432021 @default.
- W3088331243 crossrefType "journal-article" @default.
- W3088331243 hasAuthorship W3088331243A5000156180 @default.
- W3088331243 hasAuthorship W3088331243A5014097745 @default.
- W3088331243 hasAuthorship W3088331243A5029985009 @default.
- W3088331243 hasAuthorship W3088331243A5033241956 @default.
- W3088331243 hasAuthorship W3088331243A5033521569 @default.
- W3088331243 hasAuthorship W3088331243A5049145688 @default.
- W3088331243 hasAuthorship W3088331243A5059261043 @default.
- W3088331243 hasAuthorship W3088331243A5061256858 @default.
- W3088331243 hasAuthorship W3088331243A5064901843 @default.
- W3088331243 hasAuthorship W3088331243A5065195021 @default.
- W3088331243 hasAuthorship W3088331243A5083098699 @default.
- W3088331243 hasAuthorship W3088331243A5085561716 @default.
- W3088331243 hasAuthorship W3088331243A5088338989 @default.
- W3088331243 hasAuthorship W3088331243A5091666679 @default.
- W3088331243 hasBestOaLocation W30883312431 @default.
- W3088331243 hasConcept C121608353 @default.
- W3088331243 hasConcept C126322002 @default.
- W3088331243 hasConcept C126838900 @default.
- W3088331243 hasConcept C142724271 @default.
- W3088331243 hasConcept C143998085 @default.
- W3088331243 hasConcept C207103383 @default.
- W3088331243 hasConcept C2779720271 @default.
- W3088331243 hasConcept C2780849966 @default.
- W3088331243 hasConcept C2781190966 @default.
- W3088331243 hasConcept C44249647 @default.
- W3088331243 hasConcept C50382708 @default.
- W3088331243 hasConcept C71924100 @default.
- W3088331243 hasConceptScore W3088331243C121608353 @default.
- W3088331243 hasConceptScore W3088331243C126322002 @default.
- W3088331243 hasConceptScore W3088331243C126838900 @default.
- W3088331243 hasConceptScore W3088331243C142724271 @default.
- W3088331243 hasConceptScore W3088331243C143998085 @default.
- W3088331243 hasConceptScore W3088331243C207103383 @default.
- W3088331243 hasConceptScore W3088331243C2779720271 @default.
- W3088331243 hasConceptScore W3088331243C2780849966 @default.
- W3088331243 hasConceptScore W3088331243C2781190966 @default.
- W3088331243 hasConceptScore W3088331243C44249647 @default.
- W3088331243 hasConceptScore W3088331243C50382708 @default.
- W3088331243 hasConceptScore W3088331243C71924100 @default.
- W3088331243 hasLocation W30883312431 @default.
- W3088331243 hasOpenAccess W3088331243 @default.
- W3088331243 hasPrimaryLocation W30883312431 @default.
- W3088331243 hasRelatedWork W2120574916 @default.
- W3088331243 hasRelatedWork W243544667 @default.
- W3088331243 hasRelatedWork W2497296325 @default.
- W3088331243 hasRelatedWork W2761925198 @default.
- W3088331243 hasRelatedWork W2933133867 @default.
- W3088331243 hasRelatedWork W2999639531 @default.
- W3088331243 hasRelatedWork W3024003116 @default.
- W3088331243 hasRelatedWork W4200527604 @default.
- W3088331243 hasRelatedWork W4313420919 @default.
- W3088331243 hasRelatedWork W4322099846 @default.
- W3088331243 hasVolume "31" @default.
- W3088331243 isParatext "false" @default.
- W3088331243 isRetracted "false" @default.
- W3088331243 magId "3088331243" @default.
- W3088331243 workType "article" @default.